Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$547,029 | -$892,869 | -$2,106,372 | -$1,836,642 |
| Dep. & Amort. | $63,020 | $71,554 | $42,552 | $29,076 |
| Deferred Tax | -$936 | -$801 | -$14,609 | $30,212 |
| Stock-Based Comp. | $112,344 | $229,884 | $1,930,641 | $1,606,020 |
| Change in WC | -$89,670 | $29,837 | -$37,006 | -$61,537 |
| Other Non-Cash | $142,686 | $266,895 | -$67,404 | -$20,947 |
| Operating Cash Flow | -$319,585 | -$295,500 | -$252,198 | -$253,818 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$62,541 | -$40,801 | -$52,271 | -$56,521 |
| Net Acquisitions | -$5,400 | -$38,552 | $26,646 | -$12,040 |
| Inv. Purchases | $0 | $0 | -$3,691 | -$5,000 |
| Inv. Sales/Matur. | $4,519 | $0 | $0 | $0 |
| Other Inv. Act. | $1,186 | -$1,340 | -$38,078 | $304 |
| Investing Cash Flow | -$62,236 | -$80,693 | -$67,394 | -$73,257 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$897 | -$1,295 | -$1,237 | -$1,123 |
| Stock Issued | $80 | $0 | $99,303 | $0 |
| Stock Repurch. | $0 | -$23 | $0 | -$24,998 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$922 | -$1,434 | -$2,729 | $1,560,266 |
| Financing Cash Flow | -$1,739 | -$3,216 | $95,337 | $1,534,145 |
| Forex Effect | -$281 | -$588 | $908 | -$19 |
| Net Chg. in Cash | -$383,841 | -$379,997 | -$223,347 | $1,207,051 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $989,584 | $1,369,581 | $1,592,928 | $385,877 |
| End Cash | $605,743 | $989,584 | $1,369,581 | $1,592,928 |
| Free Cash Flow | -$382,126 | -$336,301 | -$304,469 | -$310,339 |